Active Ingredient History

  • Now
Procarbazine is a chemotherapy medication used for the treatment of Hodgkin's lymphoma and brain cancers. For Hodgkin's it is often used together with mechlorethamine, vincristine, and prednisone while for brain cancers such as glioblastoma multiforme it is used with lomustine and vincristine. Procarbazine inhibits DNA, RNA, and protein synthesis by inhibiting transmethylation of methionine into transfer RNA; may also damage DNA directly through alkylation. Common side effect include low blood cell counts and vomiting. Other side effects include tiredness and depression.   NCATS

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: Yes

Drug Pricing (per unit)

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

1-methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine | 2-(p-isopropylcarbamoylbenzyl)-1-methylhydrazine | 4-((2-methylhydrazino)methyl)-n-isopropylbenzamide | ibenzmethyzine | matulane | n-(1-methylethyl)-4-((2-methylhydrazino)methyl)benzamide | n-4-isopropylcarbamoylbenzyl-n'-methylhydrazine | natulan | n-isopropyl-4-[(2-methylhydrazino)methyl]benzamide | n-isopropyl-p-(2-methylhydrazinomethyl)-benzamide | n-isopropyl-α-(2-methylhydrazino)-p-toluamide | p-(2-methylhydrazinomethyl)-n-isopropylbenzamide | procarbazin | procarbazina | procarbazine | procarbazine hcl | procarbazine hydrochloride | procarbazinum | ro-46467/1 | ro-4646711


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue